Skip to content

Genome analysis on drug adverse reaction

Genome analysis on drug adverse reaction - Genome analysis on drug adverse reaction

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000015784
Enrollment
55
Registered
2014-11-28
Start date
2013-05-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant diseases

Interventions

None listed

Sponsors

Department of Medical Oncology Graduate School of Medicine, Chiba University
Lead Sponsor
Department of Genome Biology, Kinki University School of Medicine
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Individuals experienced unreported/serious adverse reaction caused by anti-neoplastic agents.

Exclusion criteria

Exclusion criteria: Not applicable

Design outcomes

Primary

MeasureTime frame
Relationship between drug adverse reactions and genome information.

Countries

Japan

Contacts

Public ContactTakiguchi, Yuichi

Graduate School of Medicine, Chiba University Department of Medical Oncology

takiguchi@faculty.chiba-u.jp043-226-2806

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026